Cover Image

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate

Saved in:

Bibliographic Details
Main Authors:	Elizabeth Docteur (Author), Joshua Cohen (Author), Brian K Bruen (Author), Ruth Lopert (Author), Avi Dor (Author), Chuck Shih (Author)
Format:	Book
Published:	Taylor & Francis Group, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
by: Elizabeth Docteur, et al.
Published: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
by: Sabine Vogler, et al.
Published: (2015)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
by: Andrew L Gray
Published: (2015)

Balancing medical innovation and affordability in the new healthcare ecosystem in China: Review of pharmaceutical pricing and reimbursement policies
by: Vivian Chen, et al.
Published: (2023)

Pharmaceutical Pricing and Reimbursement Policies: lessons learnt and perspectives for Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
by: Hajer Dahmani, et al.
Published: (2023)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
by: Dumebi O Mordi, et al.
Published: (2015)

Health technology assessment and reimbursement of pharmaceuticals in Italy
by: F. V. Gorkavenko, et al.
Published: (2019)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
by: Tomas Tesar, et al.
Published: (2021)

Ebola and the need for restructuring pharmaceutical incentives
by: Abraar Karan, et al.
Published: (2015)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
by: Bregtje W. Kamphuis, et al.
Published: (2021)

Medicines pricing and reimbursement: innovation, competitiveness, and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure
by: Anna Lukačišinová, et al.
Published: (2015)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023)

Affordable innovation: future directions in pharmaceutical policy
by: Suzanne R Hill
Published: (2015)

Budget impact analysis of the new reimbursement policy for day surgery in Thailand
by: Suphanchaimat R, et al.
Published: (2019)

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework
by: Santiago G. Moreno, et al.
Published: (2019)

Teledermatology: An updated overview of clinical applications and reimbursement policies
by: M. Campagna, et al.
Published: (2017)

Success of Big Infectious Disease Reimbursement Policy in China
by: Kun-xi Nie, et al.
Published: (2020)

Editorial: Pharmaceutical policy, impact and health outcomes
by: Hye-Young Kwon, et al.
Published: (2023)

Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria
by: Michael Kossmeier, et al.
Published: (2021)

Effectiveness evaluation of public policy incentive R&D in technological innovation in Brazil: a focus on law of the well
by: Fernando Zanghelini, et al.
Published: (2015)

Effectiveness evaluation of public policy incentive R&D in technological innovation in Brazil: a focus on law of the well
by: Fernando Zanghelini, et al.
Published: (2016)

Innovation and The Israel Journal of Health Policy Research
by: Bruce Rosen, et al.
Published: (2019)

A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges
by: Patricia Vella Bonanno, et al.
Published: (2021)

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
by: Sabine Vogler, et al.
Published: (2024)

National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation
by: Christine Årdal, et al.
Published: (2021)

The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Introducing responsible innovation in health: a policy-oriented framework
by: Hudson Pacifico Silva, et al.
Published: (2018)

Evolving teledermatology policy and reimbursement landscape in the United StatesCapsule Summary
by: Stephanie K. Lin, BA, et al.
Published: (2023)

Health Insurance Reimbursement to Hospitals in Vietnam: Policy Implementation Results and Challenges
by: Nguyen Thu Ha, et al.
Published: (2021)

A Ghost in the Machine? Politics in Global Health Policy
by: Carlos Bruen, et al.
Published: (2014)

Financial Impact of Incentive Spirometry
by: Adam E. M. Eltorai PhD, et al.
Published: (2018)

The new framework of innovation biosphere for analysing innovation policies facing COVID-19 grand challenge
by: Shohreh Nasri, et al.
Published: (2024)

Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU
by: SungKyung Lee, et al.
Published: (2023)

Selecting effective incentive structures in health care: A decision framework to support health care purchasers in finding the right incentives to drive performance
by: Klazinga Niek S, et al.
Published: (2008)

Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies
by: Tetsuji Yamada
Published: (2017)

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
by: Szczepan Jakubowski, et al.
Published: (2024)

Corrigendum to Health Insurance Reimbursement to Hospitals in Vietnam: Policy Implementation Results and Challenges
Published: (2021)